Federal Register / Vol. 72, No. 92 / Monday, May 14, 2007 / Notices 27135 

determined by the number of persons 

who register at the meeting. 

Persons registering to make oral 

comments are asked, if possible, to send 

a copy of their statement to the 

Executive Secretary for the NTP BSC 

(see ADDRESSES above) by June 8, 2007, 

to enable review by the NTP BSC prior 

to the meeting. Written statements can 

supplement and may expand the oral 

presentation. If registering on-site and 

reading from written text, please bring 

40 copies of the statement for 

distribution to the NTP BSC and NIEHS/ 

NTP staff and to supplement the record. 

Written comments received in response 

to this notice will be posted on the NTP 

Web site and persons identified by their 

name and affiliation and/or sponsoring 

organization, if applicable. Persons 

submitting written comments should 

include their name, affiliation (if 

applicable), phone, e-mail, and 

sponsoring organization (if any) with 

the document. 

Background Information on the NTP 

Board of Scientific Counselors 

The NTP BSC is a technical advisory 

body comprised of scientists from the 

public and private sectors who provide 

primary scientific oversight to the 

overall program and its centers. 

Specifically, the NTP BSC advises the 

NTP on matters of scientific program 

content, both present and future, and 

conducts periodic review of the program 

for the purposes of determining and 

advising on the scientific merit of its 

activities and their overall scientific 

quality. Its members are selected from 

recognized authorities knowledgeable in 

fields such as toxicology, pharmacology, 

pathology, biochemistry, epidemiology, 

risk assessment, carcinogenesis, 

mutagenesis, molecular biology, 

behavioral toxicology and 

neurotoxicology, immunotoxicology, 

reproductive toxicology or teratology, 

and biostatistics. Members serve 

overlapping terms of up to four years. 

NTP BSC meetings are held annually or 

biannually. 

Dated: May 3, 2007. 

Samuel H. Wilson, 

Deputy Director, National Institute of 

Environmental Health Sciences and National 

Toxicology Program. 

[FR Doc. E7–9174 Filed 5–11–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an a needed basis, scientific 

reviews of applications of AHRQ 

support. Individual members of the 

Panel do not attend regularly-scheduled 

meetings and do not serve for fixed 

terms or a long period of time. Rather, 

they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for Ambulatory Safety and 

Quality: ‘‘Enabling Patient-Centered 

Care through Health IT (R18),’’ are to be 

reviewed and discussed at this meeting. 

These discussions are likely to reveal 

personal information concerning 

individuals associated with the 

applications. This information is 

exempt from mandatory disclosure 

under the above-cited statutes. 

SEP Meeting on: Ambulatory Safety 

and Quality: Enabling Patient-Centered 

Care through Health IT (R18). 

Date: June 14–15, 2007 (Open on July 

14 from 8 a.m. to 8:15 a.m. and closed 

for the remainder of the meeting). 

Place: Hilton Washington DC/ 

Rockville Executive Meeting (Formerly 

the Doubletree Hotel), 1750 Rockville 

Pike, Rockville, Maryland 20852. 

Contact Person: Anyone wishing to 

obtain a roster of members, agenda or 

minutes of the non-confidential portions 

of this meeting should contact Mrs. 

Bonnie Campbell, Committee 

Management Officer, Office of 

Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone (301) 427–

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

May 7, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–2365 Filed 5–11–07; 8:45am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2007N–0053] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Food Labeling 

Regulations 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by June 13, 

2007. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–6974. All comments should be 

identified with the OMB control number 

0910–0381. Also include the FDA 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of the Chief 

Information Officer (HFA–250), Food 

and Drug Administration, 5600 Fishers 

Lane, Rockville, MD 20857, 301–827–

4659. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Food Labeling Regulations (OMB 

Control Number 0910–0381)—Extension 

FDA regulations require food 

producers to disclose to consumers and 

others specific information about 

themselves or their products on the 

label or labeling of their products. 

Related regulations require that food 

producers retain records establishing 

the basis for the information contained 

in the label or labeling of their products 

and provide those records to regulatory 


pwalker on PROD1PC71 with NOTICES